ClinicalTrials.govpublic full text
Phase II Study of Capecitabine and Cisplatin to Treat Metastatic Triple Negative Breast Cancer
metastatic breast cancer, triple negative breast cancer, cisplatin, capecitabine, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 874880
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.